266 related articles for article (PubMed ID: 28983073)
1. ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report.
Ray DS; Thukral S
Am J Case Rep; 2017 Oct; 18():1073-1076. PubMed ID: 28983073
[TBL] [Abstract][Full Text] [Related]
2. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
Thukral S; Shinde N; Mukherjee K; Ray DS
Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis as preconditioning protocol in an extremely high titer ABO incompatible renal transplant (ABOiRTx) case: A new prospect for chronic kidney disease patients in India.
Pandey P; Tiwari AK; Sharma J; Dixit S; Raina V
Transfus Apher Sci; 2013 Aug; 49(1):84-6. PubMed ID: 23845506
[TBL] [Abstract][Full Text] [Related]
4. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
Ray DS; Thukral S
Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
[TBL] [Abstract][Full Text] [Related]
5. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
6. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
[TBL] [Abstract][Full Text] [Related]
7. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
[TBL] [Abstract][Full Text] [Related]
8. Significance of isoagglutinin titer in ABO-incompatible kidney transplantation.
Won D; Choe W; Kim HJ; Kwon SW; Han DJ; Park SK
J Clin Apher; 2014 Oct; 29(5):243-50. PubMed ID: 24375675
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation With Uniform Protocol: Significance of Baseline Anti-ABO Titer.
Lee KW; Park JB; Oh DK; Na BG; Choi JY; Cho WT; Lee SH; Park HJ; Cho D; Huh WS; Kim SJ
Transplant Proc; 2016 Apr; 48(3):820-6. PubMed ID: 27234744
[TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible living-donor kidney transplantation in children.
Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
[TBL] [Abstract][Full Text] [Related]
11. [AB0-incompatible kidney transplantation--case 13/2009].
Guthoff M; Wernet D; Steurer W; Heyne N
Dtsch Med Wochenschr; 2009 Dec; 134(50):2577. PubMed ID: 20013598
[TBL] [Abstract][Full Text] [Related]
12. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
[TBL] [Abstract][Full Text] [Related]
13. ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.
Yabu JM; Fontaine MJ
J Clin Apher; 2015 Dec; 30(6):340-6. PubMed ID: 25739580
[TBL] [Abstract][Full Text] [Related]
14. Isoagglutinin adsorption in ABO-incompatible transplantation.
Genberg H; Kumlien G; Wennberg L; Tydén G
Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
[TBL] [Abstract][Full Text] [Related]
15. Hyperacute rejection in ABO-incompatible kidney transplantation: Significance of isoagglutinin subclass.
Yang JJ; Baek CH; Kim H; Kwon H; Shin S; Kim YH; Hwang SH; Oh HB; Park SK; Cho D; Ko DH
Transpl Immunol; 2021 Dec; 69():101484. PubMed ID: 34678463
[TBL] [Abstract][Full Text] [Related]
16. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
17. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor.
Kim JM; Kwon CH; Joh JW; Kang ES; Park JB; Lee JH; Kim SJ; Paik SW; Lee SK; Kim DW
J Hepatol; 2013 Dec; 59(6):1215-22. PubMed ID: 23928408
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with ABO-incompatible live donor renal transplantation.
Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
[TBL] [Abstract][Full Text] [Related]
20. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
Lee EC; Kim SH; Shim JR; Park SJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
